Provided by Tiger Fintech (Singapore) Pte. Ltd.

Madrigal Pharmaceuticals

345.73
+3.441.00%
Post-market: 347.501.77+0.51%17:47 EDT
Volume:353.10K
Turnover:121.73M
Market Cap:7.71B
PE:-26.98
High:348.34
Open:340.98
Low:339.31
Close:342.29
52wk High:377.46
52wk Low:200.63
Shares:22.29M
Float Shares:11.00M
Volume Ratio:0.68
T/O Rate:3.21%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-12.8155
EPS(LYR):-21.9007
ROE:-36.30%
ROA:-18.31%
PB:11.07
PE(LYR):-15.79

Loading ...

Aug 05, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2025

Major Issues Report

Form 8-K - Current report
Jul 30, 2025

Major Issues Report

Form 8-K - Current report
Jul 22, 2025

Major Issues Report

Form 8-K - Current report
Jul 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 20, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 20, 2025

Major Issues Report

Form 8-K - Current report
May 01, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 01, 2025

Major Issues Report

Form 8-K - Current report
Apr 17, 2025

Major Issues Report

Form 8-K - Current report
Mar 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 11, 2025

Major Issues Report

Form 8-K - Current report
Mar 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities